Venus Medtech (Hangzhou) Management
Management criteria checks 3/4
Venus Medtech (Hangzhou)'s CEO is Lin Haosheng Lim, appointed in Dec 2016, has a tenure of 7.58 years. total yearly compensation is CN¥57.00K, comprised of 84.2% salary and 15.8% bonuses, including company stock and options. directly owns 0% of the company’s shares, worth $881.96. The average tenure of the management team and the board of directors is 2.3 years and 2.2 years respectively.
Key information
Lin Haosheng Lim
Chief executive officer
CN¥57.0k
Total compensation
| CEO salary percentage | 84.2% |
| CEO tenure | 7.6yrs |
| CEO ownership | 0.0003% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | CN¥57k | CN¥48k | -CN¥704m |
| Sep 30 2023 | n/a | n/a | -CN¥956m |
| Jun 30 2023 | n/a | n/a | -CN¥1b |
| Mar 31 2023 | n/a | n/a | -CN¥1b |
| Dec 31 2022 | CN¥1m | CN¥1m | -CN¥1b |
| Sep 30 2022 | n/a | n/a | -CN¥759m |
| Jun 30 2022 | n/a | n/a | -CN¥461m |
| Mar 31 2022 | n/a | n/a | -CN¥417m |
| Dec 31 2021 | CN¥1m | CN¥694k | -CN¥374m |
Compensation vs Market: Lin Haosheng's total compensation ($USD7.84K) is below average for companies of similar size in the US market ($USD2.46M).
Compensation vs Earnings: Lin Haosheng's compensation has been consistent with company performance over the past year.
CEO
Lin Haosheng Lim (49 yo)
7.6yrs
Tenure
CN¥57,000
Compensation
Mr. Hou-Sen Lim, also known as Lin Haosheng, MEng. Co-founded Transcatheter Technologies GmbH in 2009 and serves as its Managing Director and Chief Technology Officer. He serves as Executive Director at Ve...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM, COO & CTO and Executive Director | 7.6yrs | CN¥57.00k | 0.00028% $ 882.0 | |
| VP & Executive Director | 1.5yrs | CN¥1.18m | no data | |
| VP of clinical medicine & Executive Director | less than a year | CN¥46.00k | 0.0084% $ 26.6k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Director of Sales | 2.3yrs | no data | no data | |
| Head of U.S. Operations | 5yrs | no data | no data | |
| Head of Venus Global Heart Valve Innovation Center | 2.3yrs | no data | no data | |
| Head of International Congenital Heart Disease Business | 2.3yrs | no data | no data | |
| Company Secretary | 3.5yrs | no data | no data |
2.3yrs
Average Tenure
48.5yo
Average Age
Experienced Management: VMTH.F's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM, COO & CTO and Executive Director | less than a year | CN¥57.00k | 0.00028% $ 882.0 | |
| VP & Executive Director | 1.5yrs | CN¥1.18m | no data | |
| VP of clinical medicine & Executive Director | less than a year | CN¥46.00k | 0.0084% $ 26.6k | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Global Advisory Board | 4.5yrs | no data | no data | |
| Independent Chairman of the Board | 5.7yrs | CN¥360.00k | no data | |
| Independent Non-Executive Director | 5yrs | CN¥360.00k | no data | |
| Shareholders Representative Supervisor | 5.7yrs | no data | no data | |
| Member of Global Advisory Board | 4.5yrs | no data | no data | |
| Employee Representative Supervisor | 1.9yrs | no data | no data | |
| Non-Executive Director | 1.5yrs | no data | no data | |
| Shareholders Representative Supervisor | 2.2yrs | no data | no data |
2.2yrs
Average Tenure
48.5yo
Average Age
Experienced Board: VMTH.F's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.